CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Encorafenib Oral Capsule + Cetuximab

Phase 2
MERCK (MRK)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
MRKPhase 2

Encorafenib Oral Capsule + Cetuximab Phase 2 Est. Readout

Encorafenib Oral Capsule + Cetuximab
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Colorectal Cancer

Clinical Trial

NCT05706779

Last updated: 9/3/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.